1
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T80981 | Tisagenlecleucel | CTL019 | |
Tisagenlecleucel (CTL019), an autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy, selectively targets and eradicates CD19-expressing B cells, and is utilized in the study of refractory aggressive diffuse... |